Hurley Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
100
0.01% 296
2026
Q1
$9.24K Hold
100
﹤0.01% 338
2025
Q4
$10.2K Hold
100
0.01% 328
2025
Q3
$6.25K Hold
100
﹤0.01% 413
2025
Q2
$5.2K Hold
100
﹤0.01% 365
2025
Q1
$4.26K Hold
100
﹤0.01% 388
2024
Q4
$3.38K Buy
+100
New +$2.81K ﹤0.01% 344

Other funds holding GH

Hurley Capital's GH Position: Q2 2026 in Review

Hurley Capital held its Guardant Health (GH) position steady in Q2 2026 at 100 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #296.

Hurley Capital first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Hurley Capital held 100 shares of Guardant Health worth $15K as of Q2 2026.
  • Hurley Capital left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up 0.01% of Hurley Capital's portfolio in Q2 2026, its #296 holding.
  • Hurley Capital first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.